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Abstract Migraine is an extremely common disorder. The
underlying mechanisms of this chronic illness interspersed
with acute symptoms appear to be increasingly complex.
An important aspect of migraine heterogeneity is comor-
bidity with other neurological diseases, cardiovascular
disorders, and psychiatric illnesses. Depressive disorders
are among the leading causes of disability worldwide
according to WHO estimation. In this review, we have
mainly considered the ﬁndings from general population
studies and studies on clinical samples, in adults and chil-
dren, focusing on the association between migraine and
psychiatric disorders (axis I of the DSM), carried over after
the ﬁrst classiﬁcation of IHS (1988). Though not easily
comparable due to differences in methodology to reach
diagnosis, general population studies generally indicate an
increased risk of affective and anxiety disorders in patients
with migraine, compared to non-migrainous subjects. There
would also be a trend towards an association of migraine
with bipolar disorder, but not with substance abuse/depen-
dence. With respect to migraine subtypes, comorbidity
mainly involves migraine with aura. Patients suffering from
migraine, however, show a decreased risk of developing
affective and anxiety disorders compared to patients with
daily chronic headache. It would also appear that psychi-
atric disorders prevail in patients with chronic headache and
substance use than in patients with simple migraine. The
mechanisms underlying migraine psychiatric comorbidity
are presently poorly understood, but this topic remains
a priority for future research. Psychiatric comorbidity
indeed affects migraine evolution, may lead to chronic
substance use, and may change treatment strategies, even-
tually modifying the outcome of this important disorder.
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Introduction
Migraine is an extremely common disorder, characterized
by the recurrence of painful and non-painful episodic
phenomena and a variety of neurological manifestations.
Nosographically, it is thus a chronic illness (migraine seen
as a ‘‘disease’’) interspersed with acute signs and symptoms
(migraine seen as an ‘‘attack’’). The mechanisms underly-
ing migraine appear to be increasingly complicated, and
the term complex disease is used to deﬁne the nature of the
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subclinical aspects that it encompasses [1, 2]. The wide
heterogeneity of migraine accounts for the observation that
the large population of migraine sufferers includes patients
living an almost normal life and patients complaining of
serious disability, i.e. facing social, affective and occupa-
tional limitations [3].
While genetic determinants are certainly at the basis of
some (and probably all) clinical forms, the contribution of
biological factors critically affects the clinical appearance
of migraine. Recent ﬁndings in the ﬁeld of neurogenetics
have altered deeply our approach to migraine, emphasising
the limits of the current diagnostic and nosographic system.
With the current diagnostic criteria of International Head-
ache Society (IHS) [4] allowing a better phenotypical
characterisation of patients, the importance of the role of
genetics in the mechanisms of migraine is increasing. In
most cases, however, migraine occurs as multifactorial
inherited character. Therefore, different genes or loci may
interact with factors intrinsic to the individual (e.g. the
hormone milieu) and/or with exogenous factors (e.g. psy-
chosocial stressors related to the family or to the working
environment, geoclimatic changes, food), generating
different clinical forms of the disease [5].
Another important aspect of migraine heterogeneity, in
close proximity to the ﬁeld of genetic determinants, is the
signiﬁcant association between migraine and other neuro-
logical diseases (such as epilepsy, cerebrovascular disor-
ders and stroke, mitochondrial diseases), cardiovascular
disorders (arterial hypertension, mitral valve prolapse), and
particularly psychiatric illnesses (anxiety, affective and
personality disorders) [6]. This non-coincidental associa-
tion of two or more diseases, referred to as comorbidity,
may result from different mutations in the same gene
(allelic disease) or mutations in genes located in neigh-
bouring segments of the same chromosome.
A further aspect of migraine heterogeneity, extremely
relevant to clinical research, is that the phenotypical
expression of comorbidity may vary over time. This
emerges upon simple observation of the natural history of
migraine in the lifetime of different individuals. The phe-
notypical manifestations remain unchanged over the years
in some patients, while in others the clinical picture
becomes more complicated, and may include arterial
hypertension (per se a risk factor for cerebrovascular
accidents) and/or anxiety and mood disturbances. On the
other hand, the presence of hypertension and psychiatric
disorders often facilitates changes in the migraine pattern,
resulting in forms of daily headache now referred to as
chronic migraine [7].
It would therefore appear that the clinical-descriptive
approach to the patient, demanded by the current diag-
nostic criteria, allows only a partial understanding of
migraine, the nature of which certainly appears to be more
complex and heterogeneous than previously thought.
Migraine psychiatric comorbidity
The relationship between migraine and certain psycho-
logical features, such as a tendency toward perfectionism,
neuroticism, repressed aggressivity and melancholic mood
has been repeatedly reported for more than a century. Over
the years, several data in the literature have been collected
on anedoctical bases. Recently, with the development of
new diagnostic criteria and statistical methodology, some
of these observations have been conﬁrmed [8, 9], but it is
impossible to compare across all previous investigations
due to differences in nosography and case deﬁnition. For
instance, earlier than 2004, some nosologic entities, such as
chronic migraine, which is frequently comorbid with
psychiatricdisorders,werenotdeﬁnedbydiagnosticcriteria.
Understanding the psychiatric correlates of migraine is
critical for several reasons. Depressive disorders are among
the leading causes of disability worldwide [10] and the
WHO estimates that major depressive disorder will become
the second leading cause of disease burden by the year
2020, second only to ischemic heart disease [11]. Migraine
is a public health problem with an enormous impact on
both the individual sufferer and on society. It is per se the
most burdensome of the primary headache disorders
[12, 13]. The presence of psychiatric conditions is a risk
factor for transformation of migraine into a chronic form
[7]. Furthermore, individuals with migraine and comorbid
psychiatric disorders are greater health resources users than
migraineurs without psychiatric conditions. Recognizing
this comorbidity should therefore result in improved
patient management, via ﬁrst-line treatment targeted at
both conditions.
In this review, we have mainly considered the studies
carried over after the publication of the ﬁrst classiﬁcation
of the IHS [14], in adults and children, focused on the
association between migraine and psychiatric disorders, as
deﬁned on axis I of the Diagnostic and Statistical Manual
of Mental Disorders (DSM) [15].
General population studies
Since the ﬁrst introduction of the IHS criteria [14], several
studies of community-drawn samples have examined
migraine psychiatric comorbidity. All cross-sectional
investigations of psychiatric disorder prevalence in
‘migraine’ compared with ‘non-migraine’ samples found
an increased risk of anxiety disorders, particularly panic
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123disorder (PD) and phobias. As for other anxiety syndromes,
one study [16] found an association between migraine and
obsessive–compulsive disorder (OCD) as well as general-
ized anxiety disorder (GAD), but these associations were
not replicated in subsequent investigations [17–19]. All
these investigations were of high methodological quality
(including rigorous sampling criteria in a community set-
ting, use of structured interviews and application of DSM
diagnostic criteria). The reasons for this discrepancy
therefore remain uncertain.
Previous investigations of mood disorders have been
highly consistent in reporting an increased prevalence of
major depressive disorder (MDD) in patients with migraine
[6]. The only one discrepant study [20] was characterized
by several methodological differences and limitations that
may account for the lack of any association between MDD
and migraine. First, the patients studied were of consider-
ably younger age and were not sex-matched by gender.
Second, the sample was not enough representative of the
general population or of clinical settings, since the study
group included young adults selected for ‘high psycho-
pathological risk’ as detected by a general symptom
scale. Finally, the recruitment of the clinical cases was
based on the use of a structured diagnostic interview
(SPIKE) originally designed for epidemiological studies
and not speciﬁcally for psychiatric diagnostic purposes. An
increased risk of current depression in migraine patients
was also reported in a community-based study [21]. This
investigation included an assessment of quality of life, and
the conclusions of the authors were that both migraine and
depressive disturbances exert a signiﬁcant but independent
impact on this parameter. Furthermore, in another study in
patients over 65 years, the risk of current depression was
found to be increased in migraine patients compared to
healthy controls [22] and headache appeared to be inde-
pendently associated with depression in the elderly. How-
ever, the diagnostic instruments in this setting included
scales not speciﬁcally intended for the assessment of DSM
criteria. Further evidence of a high prevalence of depres-
sive symptoms in adult to elderly patients with migraine
was provided by a recent cross-sectional study [23].
In patients with migraine with aura, an association was
early reported with suicide attempts, even after adjustment
of data for major depression [16]. This observation is in line
with later studies by the same group claiming that migraine
with aura is characterized by psychiatric comorbidity more
frequently than migraine without aura [24]. Interestingly,
similar ﬁndings were recently obtained in a sample of
adolescents aged 13–15 years. A higher frequency of sui-
cidal ideation was observed in younger adolescents with
migraine with aura or with high frequency of attacks, these
associations being independent of depressive symptoms
[25].
With regard to other forms of affective disorder, in one
of the studies [16] only migraine with aura was found to be
signiﬁcantly associated with bipolar disorder (BD). Later
observations did not conﬁrm this association, but they did
not distinguish between migraine subtypes [17]. Recently,
a signiﬁcant association between migraine and BD was
reported by one study [18], with migraine subjects showing
BD twice as often as those without migraine. Results were
further conﬁrmed by a subsequent, large study in a popu-
lation-based sample [19].
In cross-sectional investigations, substance-related dis-
orders have been examined in a few cases. An increased
risk of alcohol and drug abuse was reported in migraine
sufferers [16], but subsequent studies could not replicate
this ﬁnding [20]. One possible explanation for such dis-
crepancy may be related to the fact that BD and substance
abuse are highly comorbid. However, more recent studies
have shown again no association between migraine and
drug, alcohol or substance abuse/dependence [18, 19].
The prospective analyses carried over in almost all the
mentioned studies were also addressed to measure the risk
of psychiatric disorders in subjects primarily suffering from
migraine. For instance, the risk of panic disorder and
phobia onset during the follow-up period was found to be
greater for patients with migraine than for those without
migraine [26]. However, in this study, no clear signiﬁcant
association was reported between migraine and affective
disorders, at variance with other authors [28], possibly due
to the different headache diagnostic criteria used. In a study
following patients for up to 15 years, the presence of
phobia at the basal evaluation was also shown to predict the
subsequent occurrence of migraine [17]. Recently, Ratc-
liffe et al. [19] examined for the ﬁrst time the relationship
between physician-diagnosed migraine and multiple psy-
chiatric disorders in a large, nationally representative
sample. Important points overcoming the limitations of
previous studies were the use of a standardized interview
(Composite International Diagnostic Interview, CIDI)
and the fact that physical health problems were directly
diagnosed by a physician and not reported by patients.
Past-year migraine was found to be associated with
depression, dysthymia, bipolar disorder, panic attacks,
panic disorder, agoraphobia and simple phobia.
Interestingly, a recent study investigated the presence of
migraine with and without aura, probable migraine and no
migraine, according to the IHS criteria, in a large sample of
concordantly depressed sibling pairs [29]. The ﬁndings
supported the hypothesis that the two forms of migraine are
different, migraine with aura representing the extreme end
of a continuum of migraine familial liability, even in a
deﬁned psychiatric population (i.e. depressed patients).
Accordingly, in a case–control study, it was recently
observed that not only there is a general relationship
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123between recurrent headache and depression, but also a
speciﬁc association between depression and migraine with
aura [30].
Studies on clinical samples
Since the introduction of the IHS criteria (1988) [14],
several investigations have been carried over in clinic-
drawn samples, with the aim of comparing migraine with
other forms of headache (tension type headache, chronic
daily headache, transformed migraine, and daily headaches
with chronic substance abuse). None of the studies com-
paring migraine and tension-type headache could ﬁnd
signiﬁcant differences in terms of psychiatric comorbidity
[31–33], whereas the risk of psychiatric disorders was
found to be increased in chronic headache, and particularly
transformed migraine, as compared to episodic migraine
patients [33–36]. In particular, a study by our group [34]
investigated comorbidity with anxiety and depression in
several groups of patients, including low back pain
patients. While extrapolations of ﬁndings should be done
cautiously (due to the fact that patients suffering from
migraine with interval headache and patients with chronic
tension type headache were considered as a whole sample),
a signiﬁcant comorbidity was observed in all groups of
patients. Comorbidity was even more pronounced in
patients who had had chronic headache for more than
5 years than in those with shorter disease duration. Inter-
estingly, in this study all psychiatric disorders except for
somatoform disorders were found to be associated with
headache, suggesting that psychiatric comorbidity may be
conﬁned and speciﬁc to headache category, and it is not
merely accounted for by the coexistence of chronic pain.
Another study [33] compared migraine sufferers with daily
headache patients with chronic substance abuse, and found
that major depression was twice as frequent in patients with
analgesic abuse. Similarly, other authors [35] demonstrated
an increased risk of major depression, panic disorder and
social phobia in patients with transformed migraine and
chronic substance use, even after adjustment for age and
gender. Juang et al. [36] compared patients suffering from
transformed migraine with those suffering from chronic
tension-type headache, and found a higher frequency of
anxiety in transformed migraine patients after adjustment
for age and gender. However, similar to the other studies in
the ﬁeld, the role of the diagnostic criteria for substance
abuse or dependence criteria was not critically considered.
Other authors [37] found that patients with migraine show
higher severity of somatic, depressive and anxiety com-
plaints. In addition, migraine appeared to be the strongest
independent factor in predicting somatic severity of major
depressive disorder, even after controlling for anxiety
comorbidities and demographic variables. Recently, in a
cross-sectional study panic disorder was found to prevail in
migraine compared with tension-type headache or migraine
plus tension-type headache, and the association was
stronger when migraine was compared to pure tension-type
headache; similarly, obsessive–complulsive disorder was
more closely associated with migraine than to tension-type
headache [38]. The importance of the impact of psychiatric
comorbidity on chronicity and impaired quality of life in
chronic daily headache sufferers has been pointed out by a
recent selective overview [39]. In particular, the complex
interplay of factors underlying the relationship between
migraine, suicide risk and mood disorders deserve scien-
tiﬁc interest and better methododologically based investi-
gation [40].
From children to grown-up
The hypothesis of a relationship between migraine and
psychiatric disorders beginning with anxiety in childhood
and adolescence, followed by migraine and later depression
[16, 20, 26, 27] pointed the attention on the role of pedi-
atric age.
As previously reported, the presence of psychiatric
disorders is more related to severity and frequency of non-
migrainous headache than to migraine [24]. The higher
prevalence of comorbid psychiatric disorders in chronic
daily headache than other headache subtypes both in chil-
dren/adolescents and adults further supports this ﬁnding
[41]. The burden of childhood adversities on chronic daily
headache did not differ between chronic migraine and
chronic tension-type headache in a population study [11].
It has been hypothesized that chronic illness in general,
rather than a speciﬁc disorder, explains variations in psy-
chological functioning between chronically ill and healthy
children. This to stress that psychiatric disorders may not
speciﬁcally relate to migraine per se, but to migraine as a
kind of disabling and recurrent pain. Cunningham [42],
comparing migraine and chronic non-headache pain sam-
ples, found no difference in anxiety and depression levels
between the two groups with chronic pain, with respect to
pain-free controls. It is noteworthy that studies looking for
differences between migraine and other headache subtypes
did not ﬁnd speciﬁc psychological characteristics between
migraineurs and tension-type headache sufferers [32, 43].
Recently, a study comparing headache patients and patients
with recurrent abdominal pain did not ﬁnd differences by
the psychological point of view (internalizing vs. exter-
nalizing disorders) [44]. This suggests that in pediatric age
the role of psychological factors might be more related to
the frequency and severity of headaches, than to sole
migraine. Recently, a population based study on 13–15 year
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among those with migraine with aura and high frequency
non-migrainous headache; the risk increased with increas-
ing frequency of attacks [25].
From the psychiatric point of view, studies consider
often ‘‘headaches’’ and/or ‘‘abdominal pain’’ as somatic
complaints that are symptoms of child or adolescent psy-
chopathology. Livingston et al. [45] found that between 25
and 30% of children admitted to a psychiatric hospital had
physical symptoms, including headache, food intolerance,
abdominal pain, nausea and dizziness. Different interpre-
tations have been suggested by other studies. Andrasik
et al. [46] found a greater number of somatic complaints in
migraineurs and higher ratings of depression and anxiety
among migrainous adolescents, compared to matched
headache-free subjects. The suggested hypothesis was that
‘‘frequent, unexplainable and intense head pain would
likely lead to heightened levels of depression and anxiety’’.
Another aspect to be borne in mind is the presence of
subclinical conditions, such as in patients without deﬁned
psychopathology but with psychological distress following
life-events (e.g. parental divorce) or personality charac-
teristics (e.g. tendency to perfectionism), aspects that may
contribute to trigger headache. The diagnostic workup of
headache in children and adolescents should always
include a psychological assessment for a complete framing
of the clinical condition. A recent clinical study [47]
showed a connection between childhood maltreatments,
adult chronic and/or severe migraine and major depression:
migraineurs with current depression reported more frequent
physical and sexual abuse compared to those without
depression; women with major depression were more likely
to report sexual abuse occurring before 12 years, and the
relationship was stronger when abuse occurred both before
and after 12 years; women with migraine and depression
were four times more likely to have a history of some type
of childhood maltreatment. These ﬁndings outline the
interface existing between neurology and psychiatry,
organic and psychological, and likely genetic and envi-
ronmental factors linked to migraine.
A study in a psychiatric setting [48] also showed that
headache is the most frequent somatic symptom in children
and adolescents referred for emotional and behavioural
disorders, as well as in patients with depression and/or
anxiety. With regard to gender differences, females appear
to be more affected. A population, prospective cohort study
on headache adolescents [49] showed gender differences in
comorbid associations, with allergy, bronchial asthma,
diabetes mellitus and stomach-ache more common in boys,
and psychiatric symptoms and sleep disturbances in girls.
A 1-year longitudinal study in adolescent headache suf-
ferers [50] found depression, insomnia and low self-esteem
associated to headache occurrence, and a likely temporal
trend was suggested, with depression and low self-esteem
preceding headache onset, even if only in girls. However,
the study did not apply ICHD criteria and other standard-
ized (DSM-IV or ICD-10) diagnostic criteria (e.g. it was
unclear whether or not low self-esteem or insomnia were
related to depression itself). A more recent study [51]
showed an increased risk for females of reporting higher
levels of depression (and anxiety), and an elevated risk of
developing chronic daily headache and medication overuse
when patients showed psychiatric disorders as well. The
negative effect of the presence of psychiatric disorders in
general and depression in particular on the outcome is not
new in literature [41, 52], and was recently conﬁrmed in a
population based study, including a 2-year follow-up [53].
Similarly to migraine, psychiatric disorders run in
families [20]. Anxiety and mood disorders are particularly
frequent in migraineurs and their relatives [20]. A recent
study [53] showed that psychiatric disorders are equally
represented in migraine and other headache subtypes.
Noteworthy, parents of migraine children showed a sig-
niﬁcant higher comorbidity with psychiatric disorders than
parents of children with other headache subtypes. This
aspect requires attention, because it is the ﬁrst point clearly
differentiating migraineurs from other headache patients,
even if further studies are required to support this ﬁnding.
Migraine children seem to be characterized by a higher
prevalence of headache familial recurrence and psychiatric
disorders in parents, than other headache subtypes [54].
Both psychiatric comorbidity and headache familial
recurrence are also very frequent in children with other
headaches, but they can occur together or alone. This
pattern of results suggests that anxiety/depression and
headache familial recurrence act as additive factors in
non-migrainous headaches, while in migraine they might
represent, together with psychiatric disorders in parents,
interrelated aspects of a more complex relationship. This
means that the higher the weight of headache familial
recurrence the higher the possibility that children show
psychiatric comorbidity, but only in the case of migraine.
In most part of the studies in children and adolescents
with migraine, the association with anxiety (and mood)
disorders appears to be an important topic, even though a
recent systematic review suggested overall inconclusive
evidence on this matter [55]. The presence of depression is
associated with a poor outcome for any headache subtype.
Females have an increased risk for any of the above items.
Whether the association is speciﬁcally linked to recurrent
headache or to headache as a chronic pain is unclear.
Moreover, we do not know exactly what happens in chil-
dren, because depression in children has speciﬁc clinical
symptoms that complicate its recognition and diagnosis, so
that studies might have underreported or misdiagnosed it.
The aetiology of the comorbid association is also unclear,
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pharmacological treatment of the comorbid disorders due
to the young age. Like in adults, further studies based on
proper assessment tools and fulﬁlling the international
systems of classiﬁcation of both headache and mood dis-
orders are required.
Metanalysis of studies investigating the association
of migraine and depression
With particular regard to the most investigated psychiatric
comorbidity, i.e. depression, the crucial issue is whether
depression is more frequent in individuals with headache
and particularly with migraine and vice versa. An answer
to this question may arise from studies that investigated the
occurrence of these two disorders in the same population.
The most reliable design of study to provide evidence on
the association of the two diseases and on its nature is the
cohort study. This study method consists of the analysis of
the occurrence during time of depression in person with
headache without depression and in normal non-depressed
populations. The strategy for investigating the relationship
between the two diseases may obviously be reversed
looking for the occurrence of headache in depressed per-
sons without headache. Less convincing evidence on the
existence of an association between the two diseases is
derived from cross-sectional studies where the temporal
sequence of occurrence, and possible cause–effect rela-
tionship, are more hardly recognized. Another study design
for investigating the association of two diseases is the
case–control study. In case–control studies, a group of
subjects with the disease of interest (cases) is compared
with a group of subjects without the disease of interest
(controls). This type of study needs accurate study designs
in order to control for possible bias due to the effect of
confounders.
Using as key words headache or migraine and depres-
sion, we retrieved in medline 47 studies on the issue of the
relationship between headache and depression. Most are
cross-sectional, a minority are case–control studies; no
cohort studies have been retrieved. Three criteria have been
used in the selection of the papers for the metanalysis. The
ﬁrst was the consistence of the paper content with the issue
of interest. The second was the presentation of original
data. The third was the possibility of deriving crude data
from the paper, and this was a conditio sine qua non for the
execution of the metanalytic procedure. Of the 47 studies,
17 were inconsistent with the issue of the relationship
between migraine and depression; 5 were reviews or edi-
torials presenting no original data; ﬁnally, for 13 studies it
was impossible to derive the crude data. 12 studies
remained therefore available for the metanalysis (Table 1)
[7, 19, 23–25, 27, 56–60].
Table 1 shows the prevalences and the odds ratios of
depression in patients with migraine with respect to
Table 1 Prevalences and odds ratios of depression in migraineurs with respect to subjects without migraine for each one of the 12 considered
studies
Study Subject age
range (years)
Diagnostic tool Without migraine
Depression
With migraine
Depression
OR (95% CI)
No Yes (%) No Yes (%)
Ratcliffe et al. [19] 18–65 CIDI 3,762 305 (7.5) 455 79 (14.8) 2.1 (2.1–1.7)
Hung et al. [37] ND HAMD–S DSSS 62 20 (24.4) 38 35 (47.9) 2.8 (2.9–1.5)
Jette et al. [18] 15–over 65 CIDI 31,772 1,122 (3.4) 3,641 343 (8.6) 1.8 (1.8–1.6)
Camarda et al. [23] ND CES-D 1,043 242 (18.8) 80 71 (47.0) 3.8 (3.8–2.7)
Merikangas et al. [27] 27–28 SPIKE 367 29 (7.3) 52 9 (14.7) 2.2 (1.0–4.8)
Breslau et al. [56] 25–55 CIDI 453 86 (16.0) 287 209 (42.1) 3.8 (2.9–5.1)
Samaan et al. [30] 19–85 SCAN, BDI 808 1,070 (57.0) 43 189 (81.5) 3.3 (2.4–4.6)
Lipton et al. [21] 18–65 PRIME-MD 315 64 (16.9) 206 183 (47) 4.4 (3.2–6.0)
Lanteri-Minet et al. [58] ND HADS 6,651 1,264 (15.7) 1,465 442 (23.2) 1.6 (1.4–1.8)
Breslau et al. [24] 25–55 CIDI 492 94 (16.0) 318 218 (40.7) 3.6 (2.7–4.7)
Kececi et al. [59] Over 18 DSM-IV 682 102 (13.0) 110 53 (32.5) 3.2 (2.2–4.7)
McWilliams et al. [60] 25–74 CIDI-SF 1,319 185 (18.5) 243 97 (28.5) 2.8 (2.2–3.7)
2.2 (2.0–2.3)
HAMDS Somatic items of the Hamilton Depression Rating Scale, DSSS Depression and Somatic Symptoms Scale, CES-D Center for Epide-
miologic Studies Depression Scale, HADS Hospital Anxiety and Depression Scale, SCAN Schedule for Clinical Assessment in Neuropsychiatry,
BDI Beck Depression Inventory, CIDI (SF) Composite International Diagnostic Interview (Short Form), SPIKE Structured Psychopathological
Interview and Rating of the Social Consequences for Epidemiology, PRIME-MD Primary Care Evaluation of Mental Disorders
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studies. Across the studies, the prevalence estimates of
depression were highly variable, whereas the ratio of
depression prevalence between subjects with and without
migraine was more consistent. The prevalence estimates
varied from a minimum of 3.4% to a maximum of 24.4% in
individuals without migraine. The corresponding ﬁgures
among migraineurs were 8.6 and 47.9%. The individual
study odd ratios had a minimum of 1.8 and a maximum of
4.4; however, the conﬁdence limits of each study were
comprehensive of almost all the point estimates of the other
studies. The overall risk estimate gave an odd of depression
for people with migraine with respect to people without
migraine of 2.2, with a 95% conﬁdence interval of 2.0–2.3.
It should be noted that the two largest studies [18, 56]
reported the lowest odd ratios (1.6, 1.8, respectively).
Furthermore, these two studies were characterized by high
number of participants and this may have inﬂuenced the
results and decreasing the mean values of the overall
studies (Table 1).
In conclusion, all the individual studies and the overall
metanalytic investigation show that depression is almost
two time more frequent in subjects with migraine than in
people unaffected by headache.
Mechanisms of migraine psychiatric comorbidity
Comorbidity between migraine and psychiatric disorders
has been extensively studied, but the mechanisms under-
lying this phenomenon are far from clear. Direct and
indirect data mainly stem from longitudinal studies
investigating the order of onset of each condition, the
changes in severity/evolution of one disorder if another is
present, and the co-transmission of these disorders within
families. The possible mechanisms of comorbidity are
several [61]. The association of two disorders may be a
result of chance. One disorder may cause another disorder
(such as diabetes causes diabetic neuropathy). Shared
environmental risk factors may underlie both disorders
(such as head trauma causing both post-traumatic head-
ache and post-traumatic seizures). Finally, genetic or
environmental risk factors may produce a brain state
resulting in both conditions. In the latter case, common
neurobiological determinants may account for both dis-
orders, and this mechanism appears to be the most
appropriate for comorbidity of migraine and depression.
Following this conceptual view, the evidence from liter-
ature [6, 60, 61] thus points to three main potential
mechanisms, as follows:
1. psychiatric disorders are causal factors in the devel-
opment of migraine. In this case, psychiatric
disturbances are responsible for a full expression of
migraine, and under particular circumstances for the
evolution of migraine in a daily pattern (chronic
migraine)
2. migraine is a causal factor in the development of
psychiatric disorders. In this case, the repetition of
intense and/or long lasting pain episodes may facili-
tate the development of anticipatory anxiety and/or
depression
3. shared aetiological factors and common determinants
explain the co-occurrence of both entities. In this case,
there is no clear causal association, and a common
substrate (e.g., deranged activity of neurotransmitters
or receptors) may cause both migraine and the
comorbid psychiatric disorder.
With particular regard to the relationship between the
frequency of psychiatric comorbidity and the severity of
migraine, some evidence [33] suggested that there is a
signiﬁcant association between frequency and duration of
the attacks, but not with the intensity of pain. A correla-
tion was subsequently observed between the evolution of
headache and the presence of anxiety or depression. In this
respect, several studies have been focused about onset of
speciﬁc disorders. In one study [28], anxiety was shown to
precede migraine in most patients, which in turn preceded
depression. These ﬁndings were very similar to those
obtained by other authors [17, 27], indicating that the
onset of anxiety preceded that of migraine, which in turn
preceded that of depression in most patients, and that
the ages of onset of each disorder were signiﬁcantly
correlated.
With the aim of elucidating the role of psychiatric dis-
orders as possible risk factors for the onset of migraine,
some authors [17] showed that only the anamnestic pres-
ence of phobic disorder was predictive of the onset of
migraine, at variance with that of affective disorders. The
latter observation is consistent with other reports [17, 27,
28], strongly suggesting that depression and dysthymia are
not risk factors for the onset of migraine.
Other studies have investigated the reciprocal relation-
ship of migraine and psychiatric disorders. The risk of
onset of depression or panic disorder during a follow-up
period of over 1 year was found to be slightly greater in
subjects with a history of migraine (15.5%) than in subjects
with current migraine (13%) [28]. Recently, using a com-
plex statistical hazard model, the same authors [24, 63]
found no preferential order of onset for depression or panic
relative to migraine, although a trend towards an order of
onset of major depressive episodes in relation to severe
non-migraine headache was observed. All these ﬁndings
thus support the view that the comorbid disorders are
bidirectionally linked. In this regard, a follow-up study in
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headache in both migraine and tension-type headache
patients [32].
It would therefore appear that only phobic disorders
predict the onset of migraine, and that a clear bidirectional
relationship exists between migraine and depression or
panic disorder, that is, each disorder may represent a risk
factor of the other.
Comorbidity can be alternatively explained by the
hypothesis that common genetic and/or environmental risk
factors may underlie both migraine and psychiatric disor-
ders. One of the earliest reports [65], was inconclusive in
this respect, though IHS criteria were not yet available. By
duly applying IHS criteria, it was later found that there was
indeed no familial crosstransmission between migraine and
affective or anxiety disorders [20]. In another report, the
risk of bipolar disorder was not increased in the relatives of
non-bipolar migraine patients [66]. Taken together, these
studies did not support the view that depressive and bipolar
disorders share common genetic determinants with
migraine. However, everyday experience indicates that in
both migraine and affective disorders the frequency of
episodes can increase with time, and that both disorders
can progress to more chronic states with poor recovery
between episodes and development of drug resistance. This
suggests that sensitization phenomena may underlie both
disorders [67].
Biologically based studies have also tried to address the
issue of migraine psychiatric comorbidity. An association
was reported between a particular dopamine D2 receptor
genotype and comorbid migraine with aura, major
depression and generalized anxiety disorder [68]. A life-
time history of major depression was reported to be asso-
ciated with reduced tyramine conjugation (a marker of
endogenous depression) in migraine patients compared
with controls [69]. This observation argues against the
hypothesis that depression may develop as a psychological
reaction to migraine attacks. Serotonin receptors and
transporters, and catecholamines have also been implicated
in migraine as well as various psychiatric disorders [5, 70],
and there is evidence supporting the effectiveness of sev-
eral antidepressants (including SSRI abd SNRI) in the
prevention or treatment of migraine [71]. Female migrai-
neurs often experience attacks associated with falling
estrogen levels around menses, and mood disturbances in
women often coincide with menses, as well as the post-
partum period and the perimenopausal period. Ovarian
hormones, modulating numerous neurotransmitters, there-
fore appear to play an important role in migraine as well as
in depression [72]. However, the neurobiological mecha-
nisms of migraine psychiatric comorbidity are still far from
being clear.
Impact of psychiatric comorbidity on migraine
Comorbidity with psychiatric disorders raises the global
burden of migraine. Increasing evidence suggests that
migraine in comorbidity with psychiatric disorders is
associated with poorer health-related outcomes [18].
Several studies have so far examined health-related out-
comes of migraine, investigating variables such as dis-
ability, restriction of activity, quality-of-life or mental
health care utilization [73–76]. In these cases, however,
investigation was regularly restricted to migraine, without
taking into consideration any possible psychiatric comor-
bidities. When comorbidity was taken into account, in
patients suffering from both conditions the prevalence of
disability, restriction of activities, poorer quality of life
and mental health care use was found to be higher than in
those with only one of the two conditions, and even higher
than in those with neither condition [18]. Other authors
[77] reported that male patients with comorbid bipolar
disorder and migraine were more likely than those without
migraine to utilize mental health care services. The same
group found that bipolar females with comorbid migraine
were more likely to require assistance in their daily routine
when compared with bipolar females without migraine.
Patients with migraine were found more likely to have a
history of various psychiatric disorders and concomitantly
to report job absenteeism, to rate their general health as
fair or poor, and to use mental health services [28]. Recent
evidence from large populations of patients has conﬁrmed
that single-item scales are valid and reliable to assess
symptom severity, psychosocial function, and quality of
life [78]. Health-related quality of life was reported to be
generally lower in patients with comorbid migraine and
one mental health disorder [21, 63, 74]. Similarly, in
patients with MDD, the coexistence of migraine was
shown to predict a signiﬁcant negative impact on all
physical subscales and vitality in the assessment of quality
of life [79]. The same group reported that subjects with
migraine, anxiety, or chronic depression had higher
depression scores and poor quality of life; in addition
migraine, speciﬁc phobia, and panic disorder were
important and independent comorbidities predicting qual-
ity of life [80]. The presence of migraine should therefore
be considered as an important clinical symptom in all
clinic-based samples of depressed patients. However, as
already pointed out [18] the currently available studies
does not elucidate whether health-related outcome vari-
ables are speciﬁc to migraine or to mental disorders [18].
Different mechanisms may link migraine, psychiatric
disturbances and poor quality of life. In patients with
migraine and comorbid psychiatric problems, the impair-
ment in quality of life may indeed mirror a real ill
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123condition, or an altered perception of life circumstances,
or both. Prospective studies will probably help to clarify
these important points.
Conclusions
Though not easily comparable due to differences in meth-
odology to reach diagnosis (i.e. psychiatric interviews and
scales), population based studies generally indicate an
increased risk of affective and anxiety disorders in patients
with migraine, compared to non-migrainous subjects. There
would also be a trend towards an association of migraine
with bipolar disorder. By contrast, there is deﬁnitely no
comorbiditywithsubstanceabuse/dependence.Withrespect
to migraine subtypes, comorbidity (e.g. suicide attempts,
bipolar disorder) mainly involves migraine with aura rather
than the form without aura.
However, the lack of diagnostic recognition of certain
forms of migraine, such as chronic migraine, due to the use
of the ﬁrst version of IHS criteria, may have signiﬁcantly
affected the results of several studies. Another limitation is
that some of these studies were carried over within psy-
chiatric research protocols, and thus were not originally
designed to investigate the comorbidity between migraine
and psychiatric disorders.
Apparently, no signiﬁcant difference exists between
migraine and tension-type headache patients in terms of
prevalence of psychiatric comorbidity. By contrast,
patients suffering from migraine show a decreased risk of
developing affective and anxiety disorders compared to
patients with chronic daily headache. It would also appear
that affective and anxiety disorders prevail in patients with
chronic forms of headache and substance use than in
patients with migraine alone. Furthermore, patients with
‘‘transformed’’ (or chronic) migraine show an increased
prevalence of affective and anxiety disorders compared to
patients with simple migraine or chronic tension-type
headache. Although early studies suggested that there is a
correlation between frequency of headache and frequency
of anxiety or depressive disorders, little evidence support a
correlation between the severity of migraine and anxious or
depressive symptoms.
In conclusion, the mechanisms underlying migraine
psychiatric comorbidity are presently poorly understood,
but issues concerning this topic remain a priority for future
research. Psychiatric comorbidity indeed affects migraine
evolution, may lead to chronic substance use and may
change treatment strategies, eventually modifying the
outcome of this important disorder.
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